Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – In high-risk post-acute coronary syndrome (ACS) patients, a J- or U-shaped association exists between blood pressure and the risk of future cardiovascular events,…
NEW YORK (Reuters Health) – The benefits of cardiac resynchronization therapy (CRT) are less pronounced for typical “real-world” patients — particularly those with right bundle-branch block — than…
NEW YORK (Reuters Health) – Updated guidelines compiled by an expert panel of cardiologists and gastroenterologists address the issue of a possible drug interaction between proton pump inhibitors…
NEW YORK (Reuters Health) – Patients with severe aortic stenosis and reduced left ventricular systolic function may do better with transcatheter implantation of a prosthetic aortic valve than…
NEW YORK (Reuters Health) – Patients who develop acute renal failure (ARF) after undergoing coronary artery bypass grafting have a poorer prognosis if the condition doesn’t resolve within…
NEW YORK (Reuters Health) – The patency of saphenous veins used for coronary artery bypass grafting is better in the 3 months after the operation when patients are…
NEW YORK (Reuters Health) – Stent fractures are not always associated with clinical sequelae, but they do increase the likelihood of in-stent restenosis (ISR) and target lesion revascularization…
NEW YORK (Reuters Health) – Implantable cardioverter-defibrillators (ICDs) used to prevent sudden cardiac death in patients with severe left ventricular dysfunction significantly improve survival in younger patients, but…
NEW YORK (Reuters Health) – Among low-risk patients undergoing elective percutaneous coronary intervention, 1-year outcomes are worse if their antiplatelet response to clopidogrel is low, an Italian team…
NEW YORK (Reuters Health) – In patients being treated for acute coronary syndromes (ACS), the loading dose of ticagrelor has a stronger inhibitory effect on platelets than does…
